Companies›Healthcare›Healthcare›Healthcare Services

CHENNAI MEENAKSHI MULTISPECIAL

Healthcare › Healthcare Services
₹35.00
at close · 27 Oct 2026
▼ 0.01 (-0.03%)

Latest filings

Next results: Mon, 2 Nov · Financial Results
  1. Board to approve September 2026 quarterly and half-year results · Results
  2. Board reconstitutes Audit and Stakeholders committees after AGM · Management Changes
  3. Routine compliance certificate for dematerialisation of securities for Q2 FY27 · Compliance
All filings ↓
Ask Nexa about CHENNAI MEENAKSHI MULTISPECIAL

Snapshot

What the business is, and whether it's a good one at a fair price.

A Healthcare Services company listed on BSE, reporting revenue of ₹37 Cr over the trailing twelve months.

Market Cap
₹26 Cr
P / E (TTM)
—
EV / EBITDA
44.8×
Div Yield
—
Growth
13.8%▲
Revenue 5y CAGR
PAT — · EBITDA -6.8%
Quality
8.4%·
ROCE (5y median)
ROE n/m · margin 2.3%
Leverage
n/m·
Debt / Equity · negative net worth
Net debt ₹9.98 Cr
Revenue FY21→FY26
1.9×▲
Margin +3.2 pts
₹19 Cr → ₹37 Cr
Cash conversion
5.87×▲
Operating cash ÷ profit · 5 yrs
₹12 Cr on ₹2 Cr
Moves on a normal day
2.05%·
Median daily move
Last 260 sessions · the yardstick for filing-day moves
Where it sits among 29 Healthcare Service Provider peersBar = share of peers beaten · tick = industry median · latest reported figures
ROCE#26/29
EBITDA margin#18/24
Revenue growth#20/25
Profit growth#22/25

Scorecard

Measured from the filed financials, judged against its Healthcare Service Provider peers · as of FY26 — not investment advice

Strengths
Revenue compounding 14% a year over 5 years
Over 5 years it reported ₹1.97 Cr of profit and ₹12 Cr of operating cash — 5.87×
Profit is converting into cash
Negative working-capital cycle — the business is funded by its suppliers
Concerns
Erratic profits — up in only 2 of the last 5 years
Negative net worth — liabilities exceed assets by ₹3.08 Cr (FY26)
Debt-to-equity and return on equity are not meaningful below zero equity

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from CHENNAI MEENAKSHI MULTISPECIAL's filed financials and exchange disclosures

What does CHENNAI MEENAKSHI MULTISPECIAL do?

CHENNAI MEENAKSHI MULTISPECIAL is a Healthcare Services company listed on BSE.

Is CHENNAI MEENAKSHI MULTISPECIAL profitable?

No. Over the trailing twelve months CHENNAI MEENAKSHI MULTISPECIAL reported a net loss of ₹1.15 Cr on revenue of ₹37 Cr.

Does CHENNAI MEENAKSHI MULTISPECIAL pay a dividend?

Not in the latest reported year — CHENNAI MEENAKSHI MULTISPECIAL's dividend payout for FY26 was nil.

Is CHENNAI MEENAKSHI MULTISPECIAL debt-free?

No. It reported borrowings of ₹11 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹9.98 Cr after cash. Its net worth is negative — liabilities exceed assets by ₹3.08 Cr, so a debt-to-equity ratio is not meaningful.

How much does the CHENNAI MEENAKSHI MULTISPECIAL share price move in a day?

On a typical session CHENNAI MEENAKSHI MULTISPECIAL moves 2.05% — that is the median absolute close-to-close move across its last 260 trading days. MarketPing measures each filing's price reaction against it.

When are CHENNAI MEENAKSHI MULTISPECIAL's next results?

Financial Results on Mon, 2 Nov. MarketPing alerts you on WhatsApp the moment the filing lands.

Where can I track CHENNAI MEENAKSHI MULTISPECIAL's announcements?

Every NSE and BSE filing by CHENNAI MEENAKSHI MULTISPECIAL appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.